National and Kapodistrian University of Athens
Μελέτη υποπληθυσμών των λεμφοκυττάρων των όγκων σε καρκίνο ωοθηκών: συσχέτιση με την παραγωγή κυτταροκινών και διερεύνηση της προγνωστικής τους σημασίας
Abstract
dc:descriptionIntroductionEpithelial ovarian cancer (EOC) is the leading cause of death among gynecological malignancies and the fourth most common cause of cancer-related deaths among women. In the majority of cases the disease is diagnosed in advanced stages (International Federation of Gynecology and Obstetrics [FIGO] stages III and IV). Current treatment includes surgical cytoreduction and post-surgery platinum–paclitaxel chemotherapy. Despite the initial response to treatment, relapse (and death from the disease) will still occur in 70% of patients. Established prognostic factors for EOC include stage, volume of residual disease after cytoreductive surgery, histologic subtype and tumor grade. Nevertheless, given the fact that most cases are diagnosed at advanced stages, with tumors of high grade, the prognostic value of these factors is limited. Therefore, there is a need for the identification of new prognostic factors, which could probably be useful in the decision-making process. Ovarian carcinoma may be recognized and attacked by the immune system. Ovarian cancer antigens provoke an immune response which results in lymphocytic infiltration of the tumor. Recent data support that the presence of tumor-infiltrating lymphocytes and cytokines has been associated with immunoregulation and prognosis in ovarian cancer. Most patients with advanced ovarian cancer have ascites. An abundant quantity of cancer cells, lymphocytes and ascitic fluid can easily be obtained by abdominal paracentesis. Ascitic cell subpopulations and ascitic cytokines levels are parts of the intraperitoneal model employed in studying ovarian cancer. This model may recapitulate the immune events against ovarian cancer that take place in the human in a more accurate way than mouse models or cell cultures.Objective The aim of this study was to investigate:A) differences in VEGF (vascular endothelial growth factor), TNF-α (tumor necrosis factor-α), IFN-γ (interferon-gamma), IL-10 (interleukin-10) and IL-12 (interleukin-12) levels as well as in lymphocytic subpopulations between ascitic fluid and serum of patients with epithelial ovarian cancerB) the association of cytokines in the ascites from patients with ovarian cancer with these lymphocytic subpopulations C) the association of the results to be found with the platinum resistance and the prognosis of these patientsPatients and methodsFrom June 2004 to December 2006, samples of ascites and peripheral blood from 64 patients with ovarian cancer were obtained. Ascites was obtained at initial diagnosis in 42 cases (40 of them FIGO stage III). In the remaining 22 cases, ascites was obtained at the time of relapse. Cell subpopulations from peripheral blood and ascites were stained with monoclonal antibodies and analyzed by flow cytometry to determine cell type and immunophenotype. Flow cytometry analyses were performed on a three-colour fluorescence cytometer. VEGF (vascular endothelial growth factor), TNF-α (tumor necrosis factor-α), IFN-γ (interferon-gamma), IL-10 (interleukin-10) and IL-12 (interleukin-12) in ascites and serum of the 64 patients and 9 controls were measured by ELISA (enzyme-linked immunosorbent assay).ResultsCD3+CD56+ and CD4+CD25+ (hi) cells were significantly higher in ascites than blood from ovarian cancer patients (p=0,004 and p=0,03 respectively). CD3+CD56+ (NK-like T) were also selectively accumulated in ascites from ovarian cancer compared with controls (p=0,011). VEGF, TNF-α and IL10 were significantly higher in ascites than in serum in ovarian cancer patients (p<0,001, p=0,042 and p<0,001 respectively). VEGF levels were significantly higher in ascites from ovarian cancer than from controls (p<0.001), while IL-12 was significantly lower in ascites from ovarian cancer than from cirrhotic ascites (p= 0,029). Serum VEGF and IL-12 levels were also significantly higher among ovarian cancer patients compared to controls (p < 0,001 both). VEGF ascites levels were inversely correlated with CD3+CD56+ cells in ascites (rho=−0.316, p=0.012). A similar inverse correlation was observed between TNF-α ascites levels and CD4+CD25+ (hi) cells in ascites (rho=−0.332, p=0.041). Among patients receiving first-line chemotherapy, VEGF levels <1900 pg/ml and TNF-α levels >35 pg/ml were associated with platinum sensitivity (p=0.026 both) and improved progression-free survival (PFS) (p=0.007 and p=0.036, respectively). VEGF levels <1900 pg/ml were also associated with improved overall survival (p=0.026). Overall survival was also longer for patients with high TNF-α levels, but this difference did not reach statistical significance (p=0.154).ConclusionsVEGF and TNF-α ascites levels are associated with prognosis in advanced ovarian cancer. Their association with immunologically important populations, namely the CD3+CD56+ (NK T-like) cells and the CD4+CD25+ (hi) (Tregs) cells, respectively may account for their prognostic significance in advanced ovarian cancer. This may probably be useful in making therapeutic decisions.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koutsoukou, Vassiliki
- Κουτσούκου, Βασιλική
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28832